Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP625397.RAUa6fjYw5b3PPhnUqjmyPPsV7TlQ-orJYzzKTTFCLM1c130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP625397.RAUa6fjYw5b3PPhnUqjmyPPsV7TlQ-orJYzzKTTFCLM1c130_assertion type Assertion NP625397.RAUa6fjYw5b3PPhnUqjmyPPsV7TlQ-orJYzzKTTFCLM1c130_head.
- NP625397.RAUa6fjYw5b3PPhnUqjmyPPsV7TlQ-orJYzzKTTFCLM1c130_assertion description "[Furthermore, the possibility of selective targeting of PTEN mutant tumor cells by specific pharmacologic inhibitors of members of the Pten/PI3K/Akt pathway opens up new perspectives for a targeted molecular therapy of malignant gliomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625397.RAUa6fjYw5b3PPhnUqjmyPPsV7TlQ-orJYzzKTTFCLM1c130_provenance.
- NP625397.RAUa6fjYw5b3PPhnUqjmyPPsV7TlQ-orJYzzKTTFCLM1c130_assertion evidence source_evidence_literature NP625397.RAUa6fjYw5b3PPhnUqjmyPPsV7TlQ-orJYzzKTTFCLM1c130_provenance.
- NP625397.RAUa6fjYw5b3PPhnUqjmyPPsV7TlQ-orJYzzKTTFCLM1c130_assertion SIO_000772 12084351 NP625397.RAUa6fjYw5b3PPhnUqjmyPPsV7TlQ-orJYzzKTTFCLM1c130_provenance.
- NP625397.RAUa6fjYw5b3PPhnUqjmyPPsV7TlQ-orJYzzKTTFCLM1c130_assertion wasDerivedFrom befree-20150227 NP625397.RAUa6fjYw5b3PPhnUqjmyPPsV7TlQ-orJYzzKTTFCLM1c130_provenance.
- NP625397.RAUa6fjYw5b3PPhnUqjmyPPsV7TlQ-orJYzzKTTFCLM1c130_assertion wasGeneratedBy ECO_0000203 NP625397.RAUa6fjYw5b3PPhnUqjmyPPsV7TlQ-orJYzzKTTFCLM1c130_provenance.